Abstract | BACKGROUND: METHODS: Blood specimens of 2,935 HCWs at 6 major hospitals in Daegu from January 2021 to February 2021 were collected. Every specimen was tested for antibody against SARS-CoV-2 using both Elecsys Anti-SARS-CoV-2 electrochemiluminescence immunoassay (Roche Diagnostics, Rotkreuz, Switzerland) and R-FIND COVID-19 IgG/M/A enzyme-linked immunosorbent assay kit (SG medical Inc., Seoul, Korea) as screening tests. If 1 or more of these screening test results was positive, 2 additional antibody tests were performed using Abbott Anti-SARS-CoV-2 IgG assay (Abbott, Abbott Park, IL, USA) and cPass SARS-CoV-2 Neutralization Antibody Detection Kit (GenScript USA Inc., Piscataway, NJ, USA). If 2 or more of the total 4 test results were positive, it was determined as positive for the antibody against SARS-CoV-2. RESULTS: According to the criteria of SARS-CoV-2 antibody positivity determination, 12 subjects were determined as positive. The overall positive rate of the SARS-CoV-2 antibody was 0.41% (12/2,935). Of the 12 subjects determined as positive, 7 were diagnosed with COVID-19, and the remaining 5 were nondiagnosed cases of COVID-19. CONCLUSION: In early 2021, the overall seroprevalence of SARS-CoV-2 antibody among HCW located in Daegu was 0.41%, and 0.17% excluding COVID-19 confirmed subjects. These results were not particularly high compared with the general public and were much lower than HCWs in other countries.
|
Authors | Yu Kyung Kim, Dohsik Minn, Do Young Song, Chae Hoon Lee, Nam Hee Ryoo, Chang-Ho Jeon, Kyung Eun Song, Jang Soo Suh, Soon Hee Chang |
Journal | Journal of Korean medical science
(J Korean Med Sci)
Vol. 36
Issue 43
Pg. e294
(Nov 08 2021)
ISSN: 1598-6357 [Electronic] Korea (South) |
PMID | 34751011
(Publication Type: Journal Article)
|
Copyright | © 2021 The Korean Academy of Medical Sciences. |
Chemical References |
- Antibodies, Neutralizing
- Antibodies, Viral
- Immunoglobulin A
- Immunoglobulin G
- Immunoglobulin M
|
Topics |
- Adult
- Aged
- Antibodies, Neutralizing
- Antibodies, Viral
(blood)
- Antibody Specificity
- COVID-19
(diagnosis, epidemiology, immunology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Health Personnel
(statistics & numerical data)
- Hospitals
- Humans
- Immunoglobulin A
(blood)
- Immunoglobulin G
(blood)
- Immunoglobulin M
(blood)
- Male
- Middle Aged
- Prevalence
- Republic of Korea
(epidemiology)
- SARS-CoV-2
|